Likelihood of amyloid formation in COVID-19-induced ARDS

Severe coronavirus disease 2019 (COVID-19) infection leads to multifactorial acute respiratory distress syndrome (ARDS), with little therapeutic success. The pathophysiology associated with ARDS or post-ARDS is not yet well understood. We hypothesize that amyloid formation occurring due to protein h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Nabodita, Thakur, Ashwani K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007089/
https://www.ncbi.nlm.nih.gov/pubmed/33795156
http://dx.doi.org/10.1016/j.tim.2021.03.008
_version_ 1783672426398220288
author Sinha, Nabodita
Thakur, Ashwani K.
author_facet Sinha, Nabodita
Thakur, Ashwani K.
author_sort Sinha, Nabodita
collection PubMed
description Severe coronavirus disease 2019 (COVID-19) infection leads to multifactorial acute respiratory distress syndrome (ARDS), with little therapeutic success. The pathophysiology associated with ARDS or post-ARDS is not yet well understood. We hypothesize that amyloid formation occurring due to protein homeostasis disruption can be one of the complications associated with COVID-19-induced-ARDS.
format Online
Article
Text
id pubmed-8007089
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80070892021-03-30 Likelihood of amyloid formation in COVID-19-induced ARDS Sinha, Nabodita Thakur, Ashwani K. Trends Microbiol Forum Severe coronavirus disease 2019 (COVID-19) infection leads to multifactorial acute respiratory distress syndrome (ARDS), with little therapeutic success. The pathophysiology associated with ARDS or post-ARDS is not yet well understood. We hypothesize that amyloid formation occurring due to protein homeostasis disruption can be one of the complications associated with COVID-19-induced-ARDS. Elsevier Ltd. 2021-11 2021-03-29 /pmc/articles/PMC8007089/ /pubmed/33795156 http://dx.doi.org/10.1016/j.tim.2021.03.008 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Forum
Sinha, Nabodita
Thakur, Ashwani K.
Likelihood of amyloid formation in COVID-19-induced ARDS
title Likelihood of amyloid formation in COVID-19-induced ARDS
title_full Likelihood of amyloid formation in COVID-19-induced ARDS
title_fullStr Likelihood of amyloid formation in COVID-19-induced ARDS
title_full_unstemmed Likelihood of amyloid formation in COVID-19-induced ARDS
title_short Likelihood of amyloid formation in COVID-19-induced ARDS
title_sort likelihood of amyloid formation in covid-19-induced ards
topic Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007089/
https://www.ncbi.nlm.nih.gov/pubmed/33795156
http://dx.doi.org/10.1016/j.tim.2021.03.008
work_keys_str_mv AT sinhanabodita likelihoodofamyloidformationincovid19inducedards
AT thakurashwanik likelihoodofamyloidformationincovid19inducedards

Ejemplares similares